|
|
   Nizatidine
|
|
|
| appearance as argument number 1 |
|
|
| (diseaseMedicine Nizatidine PepticUlcers Ingesting) | Medicine.kif 4968-4968 | Nizatidine is disease treatment stomach ulcers for ingesting |
| (documentation Nizatidine EnglishLanguage "Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. It was patented in 1980 and approved for medical use in 1988. It was developed by Eli Lilly. Brand names include Tazac and Axid. [from Wikipedia]") | Medicine.kif 4957-4962 | |
| (subclass Nizatidine Medicine) | Medicine.kif 4956-4956 | Nizatidine is a subclass of medicine |
| appearance as argument number 2 |
|
|
| (subclass Axid Nizatidine) | Medicine.kif 4984-4984 | Axid is a subclass of Nizatidine |
| (subclass Tazac Nizatidine) | Medicine.kif 4981-4981 | Tazac is a subclass of Nizatidine |
| (termFormat EnglishLanguage Nizatidine "Nizatidine") | Medicine.kif 4963-4963 |
|
|
|